SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-355669
Filing Date
2017-11-29
Accepted
2017-11-29 16:10:03
Documents
1
Group Members
JONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D d499631dsc13d.htm SC 13D 155386
  Complete submission text file 0001193125-17-355669.txt   157217
Mailing Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90199 | Film No.: 171228425
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1